What's the SIOP2001 clinical trial about?
The SIOP2001 clinical trial focused on Wilms tumor, a rare childhood kidney cancer. It aimed to assess the impact of liver metastases on the outcome of patients with Wilms tumor, showing that liver involvement did not appear to be an adverse prognostic factor in metastatic Wilms tumor. The trial also explored the role of hepatic surgery and radiotherapy in cases of persistent liver metastases, emphasizing the importance of considering histology and radiological response to other metastatic sites. Additionally, the trial incorporated genetic analysis, specifically investigating the prognostic significance of chromosome arm 1q gain in Wilms tumors, highlighting its association with inferior event-free survival and overall survival rates. The SIOP2001 trial contributed valuable insights into the treatment and prognosis of Wilms tumor, enhancing understanding and management strategies for this pediatric malignancy.
Answers from top 5 papers
Papers (5) | Insight |
---|---|
109 Citations | The SIOP 93-01/GPOH trial focused on preoperative therapy for unilateral nonmetastatic Wilms tumor, evaluating reducing postoperative chemotherapy without compromising efficacy based on tumor volume and histology. |
Not addressed in the paper. | |
5 Citations | The SIOP2001 trial studied liver metastasis impact on children with Wilms tumor. Liver involvement didn't affect prognosis; hepatic surgery and radiotherapy roles need clarification for persistent metastases. |
01 Nov 2017 | Not addressed in the paper. |
The SIOP2001 clinical trial focuses on risk stratification in Wilms tumors based on stage and histopathologic classification after preoperative chemotherapy, with limited prognostic value for 1q gain. |